Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 5/20 | 0.72 |
| ▸ | NR1H3 | Q13133 | 2/20 | 0.67 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.67 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.67 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.65 |
| ▸ | HTT | P42858 | 3/20 | 0.60 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.59 |
| ▸ | MAPT | P10636 | 2/20 | 0.59 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.58 |
| ▸ | MAPK1 | P28482 | 5/20 | 0.58 |
| ▸ | HPGD | P15428 | 2/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11743353 | 0.92 | ALDH1A1 (0.69) | LMNANR1H3HSP90AA1NR1H2ALDH1A1 | |
| SCHEMBL9053567 | 0.89 | ALDH1A1 (0.67) | LMNANR1H3HSP90AA1NR1H2ALDH1A1 | |
| SCHEMBL3193194 | 0.87 | LMNA (0.57) | LMNANR1H3HSP90AA1NR1H2ALDH1A1 | |
| SCHEMBL8828667 | 0.86 | ABCB1 (0.69) | LMNANR1H3NR1H2ALDH1A1 | |
| SCHEMBL4854039 | 0.85 | NR1H3 (0.62) | LMNANR1H3NR1H2ALDH1A1HTT | |
| SCHEMBL2593843 | 0.85 | ALDH1A1 (0.64) | LMNANR1H3HSP90AA1NR1H2ALDH1A1 | |
| SCHEMBL476943 | 0.83 | KMT2A (0.76) | LMNANR1H3NR1H2ALDH1A1SMN1; SMN2 | |
| SCHEMBL15693967 | 0.82 | ALDH1A1 (0.59) | LMNANR1H3NR1H2ALDH1A1SMN1; SMN2 | |
| SCHEMBL11635816 | 0.82 | PARK7 (0.59) | LMNAHSP90AA1ALDH1A1HTTSMN1; SMN2 | |
| SCHEMBL10669409 | 0.82 | NR1H3 (0.53) | LMNANR1H3HSP90AA1NR1H2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-61140547-A | — | — | None | — | — | JP | disclosed |
| WO-2017049409-A1 | COMPOSITIONS FOR PROMOTING READTHROUGH OF PREMATURE TERMINATION CODONS, AND METHODS OF USING THE SAME | THE CENTRE FOR DRUG RESEARCH AND DEVELOPMENT (CA) | 2017-03-30 | — | — | WO | disclosed |
| WO-2017049409-A1 | COMPOSITIONS FOR PROMOTING READTHROUGH OF PREMATURE TERMINATION CODONS, AND METHODS OF USING THE SAME | THE CENTRE FOR DRUG RESEARCH AND DEVELOPMENT (CA) | 2017-03-30 | — | — | WO | disclosed |
| EP-0800514-A1 | SUBSTITUTED IMIDES AS TNF INHIBITORS | CELGENE CORPORATION (US) | 1997-10-15 | — | — | EP | disclosed |
| WO-1996020926-A9 | SUBSTITUTED IMIDES AS TNF INHIBITORS | — | 1996-09-26 | — | — | WO | disclosed |
| WO-1996020926-A1 | SUBSTITUTED IMIDES AS TNF INHIBITORS | CELGENE CORPORATION (US) | 1996-07-11 | — | — | WO | disclosed |
| JP-S61140547-A | PHENETHYLAMINE DERIVATIVE AND DIAGNOSTIC METABOLIC ACTIVATOR | SEITAI KAGAKU KENKYUSHO:KK | 1986-06-27 | — | — | JP | disclosed |
| US-4128650-A | Dibenzo[de, h]quinoline derivatives | RHONE-POULENC INDUSTRIES (FR) | 1978-12-05 | — | — | US | disclosed |